Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
The Latest on: Alzheimer’s Disease
via Google News
The Latest on: Alzheimer’s Disease
- Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer's disease on November 13, 2018 at 11:46 pm
Alzheimer's disease (AD) is a progressive, neurodegenerative condition in which individuals exhibit memory loss, dementia, and impaired metabolism. Nearly all previous single-domain studies to treat A... […]
- Kennedy Center hosts Down syndrome, Alzheimer’s forum on November 13, 2018 at 4:05 pm
TRUMBULL — The Kennedy Center will host a complimentary education community forum later this month focused on Alzheimer’s disease and Down syndrome. The event will be on Thursday, Nov. 29 at The Kenne... […]
- Finding a new way to attack Alzheimer's on November 13, 2018 at 3:32 pm
Retired Supreme Court Justice Sandra Day O’Connor recently revealed she likely has Alzheimer’s disease, joining nearly 5.5 million people who struggle with the disease. While scientists are searching ... […]
- Alex Trebek Reveals He Was Tested for Alzheimer's Disease After Experiencing Memory Lapses on November 13, 2018 at 2:57 pm
Alex Trebek is opening up about his Alzheimer's disease scare. The Jeopardy! icon revealed in an interview with Vulture on Monday that he recently underwent a test for early onset Alzheimer's, after n... […]
- New methods to identify Alzheimer's drug candidates with anti-aging properties on November 13, 2018 at 10:35 am
Credit: Salk Institute Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. […]
- New Report Offers Road Map to Reduce Alzheimer's Risk on November 13, 2018 at 7:31 am
published details on a comprehensive Alzheimer’s disease risk reduction program created by the Alzheimer’s Prevention Clinic (APC) at Weill Cornell Medicine in New York City. The APC focuses on early ... […]
- Biogen CEO Sees Room to Pursue Two Similar Alzheimer's Hopefuls on November 13, 2018 at 7:04 am
Biogen Inc. may push ahead with a pair of similar experimental treatments for Alzheimer’s disease, making a concentrated wager in a field littered with failures. While the company’s biggest hope in Al... […]
- Meditation and music may alter blood markers of cellular aging and Alzheimer's disease on November 13, 2018 at 5:22 am
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain ... […]
- Forum on Alzheimer's, other dementias set on November 12, 2018 at 8:01 pm
HUNTINGTON — Residents from the Tri-State area are invited to take part in an upcoming community forum on Alzheimer's disease and other dementias. The forum, set for 5:30 p.m. Thursday, Nov. 29, in Co... […]
via Bing News